key: cord-0990869-bek0fwwd authors: Struyf, Thomas; Deeks, Jonathan J; Dinnes, Jacqueline; Takwoingi, Yemisi; Davenport, Clare; Leeflang, Mariska MG; Spijker, René; Hooft, Lotty; Emperador, Devy; Domen, Julie; Tans, Anouk; Janssens, Stéphanie; Wickramasinghe, Dakshitha; Lannoy, Viktor; Horn, Sebastiaan R A; Van den Bruel, Ann title: Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 date: 2022-05-20 journal: Cochrane Database Syst Rev DOI: 10.1002/14651858.cd013665.pub3 sha: 23450d06fa925969c70cf2cff9007cbc3a364036 doc_id: 990869 cord_uid: bek0fwwd BACKGROUND: COVID‐19 illness is highly variable, ranging from infection with no symptoms through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough, or loss of sense of smell (anosmia) or taste (ageusia), can help flag early on if the disease is present. Such information could be used either to rule out COVID‐19 disease, or to identify people who need to go for COVID‐19 diagnostic tests. This is the second update of this review, which was first published in 2020. OBJECTIVES: To assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID‐19 clinics, has COVID‐19. SEARCH METHODS: We undertook electronic searches up to 10 June 2021 in the University of Bern living search database. In addition, we checked repositories of COVID‐19 publications. We used artificial intelligence text analysis to conduct an initial classification of documents. We did not apply any language restrictions. SELECTION CRITERIA: Studies were eligible if they included people with clinically suspected COVID‐19, or recruited known cases with COVID‐19 and also controls without COVID‐19 from a single‐gate cohort. Studies were eligible when they recruited people presenting to primary care or hospital outpatient settings. Studies that included people who contracted SARS‐CoV‐2 infection while admitted to hospital were not eligible. The minimum eligible sample size of studies was 10 participants. All signs and symptoms were eligible for this review, including individual signs and symptoms or combinations. We accepted a range of reference standards. DATA COLLECTION AND ANALYSIS: Pairs of review authors independently selected all studies, at both title and abstract, and full‐text stage. They resolved any disagreements by discussion with a third review author. Two review authors independently extracted data and assessed risk of bias using the QUADAS‐2 checklist, and resolved disagreements by discussion with a third review author. Analyses were restricted to prospective studies only. We presented sensitivity and specificity in paired forest plots, in receiver operating characteristic (ROC) space and in dumbbell plots. We estimated summary parameters using a bivariate random‐effects meta‐analysis whenever five or more primary prospective studies were available, and whenever heterogeneity across studies was deemed acceptable. MAIN RESULTS: We identified 90 studies; for this update we focused on the results of 42 prospective studies with 52,608 participants. Prevalence of COVID‐19 disease varied from 3.7% to 60.6% with a median of 27.4%. Thirty‐five studies were set in emergency departments or outpatient test centres (46,878 participants), three in primary care settings (1230 participants), two in a mixed population of in‐ and outpatients in a paediatric hospital setting (493 participants), and two overlapping studies in nursing homes (4007 participants). The studies did not clearly distinguish mild COVID‐19 disease from COVID‐19 pneumonia, so we present the results for both conditions together. Twelve studies had a high risk of bias for selection of participants because they used a high level of preselection to decide whether reverse transcription polymerase chain reaction (RT‐PCR) testing was needed, or because they enrolled a non‐consecutive sample, or because they excluded individuals while they were part of the study base. We rated 36 of the 42 studies as high risk of bias for the index tests because there was little or no detail on how, by whom and when, the symptoms were measured. For most studies, eligibility for testing was dependent on the local case definition and testing criteria that were in effect at the time of the study, meaning most people who were included in studies had already been referred to health services based on the symptoms that we are evaluating in this review. The applicability of the results of this review iteration improved in comparison with the previous reviews. This version has more studies of people presenting to ambulatory settings, which is where the majority of assessments for COVID‐19 take place. Only three studies presented any data on children separately, and only one focused specifically on older adults. We found data on 96 symptoms or combinations of signs and symptoms. Evidence on individual signs as diagnostic tests was rarely reported, so this review reports mainly on the diagnostic value of symptoms. Results were highly variable across studies. Most had very low sensitivity and high specificity. RT‐PCR was the most often used reference standard (40/42 studies). Only cough (11 studies) had a summary sensitivity above 50% (62.4%, 95% CI 50.6% to 72.9%)); its specificity was low (45.4%, 95% CI 33.5% to 57.9%)). Presence of fever had a sensitivity of 37.6% (95% CI 23.4% to 54.3%) and a specificity of 75.2% (95% CI 56.3% to 87.8%). The summary positive likelihood ratio of cough was 1.14 (95% CI 1.04 to 1.25) and that of fever 1.52 (95% CI 1.10 to 2.10). Sore throat had a summary positive likelihood ratio of 0.814 (95% CI 0.714 to 0.929), which means that its presence increases the probability of having an infectious disease other than COVID‐19. Dyspnoea (12 studies) and fatigue (8 studies) had a sensitivity of 23.3% (95% CI 16.4% to 31.9%) and 40.2% (95% CI 19.4% to 65.1%) respectively. Their specificity was 75.7% (95% CI 65.2% to 83.9%) and 73.6% (95% CI 48.4% to 89.3%). The summary positive likelihood ratio of dyspnoea was 0.96 (95% CI 0.83 to 1.11) and that of fatigue 1.52 (95% CI 1.21 to 1.91), which means that the presence of fatigue slightly increases the probability of having COVID‐19. Anosmia alone (7 studies), ageusia alone (5 studies), and anosmia or ageusia (6 studies) had summary sensitivities below 50% but summary specificities over 90%. Anosmia had a summary sensitivity of 26.4% (95% CI 13.8% to 44.6%) and a specificity of 94.2% (95% CI 90.6% to 96.5%). Ageusia had a summary sensitivity of 23.2% (95% CI 10.6% to 43.3%) and a specificity of 92.6% (95% CI 83.1% to 97.0%). Anosmia or ageusia had a summary sensitivity of 39.2% (95% CI 26.5% to 53.6%) and a specificity of 92.1% (95% CI 84.5% to 96.2%). The summary positive likelihood ratios of anosmia alone and anosmia or ageusia were 4.55 (95% CI 3.46 to 5.97) and 4.99 (95% CI 3.22 to 7.75) respectively, which is just below our arbitrary definition of a 'red flag', that is, a positive likelihood ratio of at least 5. The summary positive likelihood ratio of ageusia alone was 3.14 (95% CI 1.79 to 5.51). Twenty‐four studies assessed combinations of different signs and symptoms, mostly combining olfactory symptoms. By combining symptoms with other information such as contact or travel history, age, gender, and a local recent case detection rate, some multivariable prediction scores reached a sensitivity as high as 90%. AUTHORS' CONCLUSIONS: Most individual symptoms included in this review have poor diagnostic accuracy. Neither absence nor presence of symptoms are accurate enough to rule in or rule out the disease. The presence of anosmia or ageusia may be useful as a red flag for the presence of COVID‐19. The presence of cough also supports further testing. There is currently no evidence to support further testing with PCR in any individuals presenting only with upper respiratory symptoms such as sore throat, coryza or rhinorrhoea. Combinations of symptoms with other readily available information such as contact or travel history, or the local recent case detection rate may prove more useful and should be further investigated in an unselected population presenting to primary care or hospital outpatient settings. The diagnostic accuracy of symptoms for COVID‐19 is moderate to low and any testing strategy using symptoms as selection mechanism will result in both large numbers of missed cases and large numbers of people requiring testing. Which one of these is minimised, is determined by the goal of COVID‐19 testing strategies, that is, controlling the epidemic by isolating every possible case versus identifying those with clinically important disease so that they can be monitored or treated to optimise their prognosis. The former will require a testing strategy that uses very few symptoms as entry criterion for testing, the latter could focus on more specific symptoms such as fever and anosmia. Anosmia COVID-19 illness is highly variable, ranging from infection with no symptoms through to pneumonia and life-threatening consequences. Symptoms such as fever, cough, or loss of sense of smell (anosmia) or taste (ageusia), can help flag early on if the disease is present. Such information could be used either to rule out COVID-19 disease, or to identify people who need to go for COVID-19 diagnostic tests. This is the second update of this review, which was first published in 2020. To assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID-19 clinics, has COVID-19. We undertook electronic searches up to 10 June 2021 in the University of Bern living search database. In addition, we checked repositories of COVID-19 publications. We used artificial intelligence text analysis to conduct an initial classification of documents. We did not apply any language restrictions. Target condition: SARS-CoV-2 infection (symptomatic of any severity); mild or moderate COVID-19; severe or critical COVID-19 Reference standard: RT-PCR Top 10 of most reported symptoms to determine if a patient presenting in primary care or hospital outpatient setting has COVID-19 (prospective cross-sectional studies only). We estimated pooled sensitivity and specificity only for prospective studies with a low risk of bias rating for participant selection. Cochrane Database of Systematic Reviews The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and resulting COVID-19 pandemic present important diagnostic evaluation challenges. These range from, on the one hand, understanding the value of signs and symptoms in predicting possible infection, assessing whether existing biochemical and imaging tests can identify infection and recognise patients needing critical care, and on the other hand, evaluating whether new diagnostic tests can allow accurate rapid and point-of-care testing. Also, the diagnostic aims are diverse, including identifying current infection, ruling out infection, identifying people in need of care escalation, or testing for past infection and immunity. This review is the second update of a review summarising evidence of the diagnostic accuracy of presenting clinical signs and symptoms for COVID-19. This review is part of a suite of reviews on the diagnosis of SARS-CoV-2 infection and COVID-19 disease, exploring the accuracy of antibody tests (Deeks 2020a), routine laboratory testing (Stegeman 2020), rapid point-of-care tests (Dinnes 2021) and thoracic imaging tests (Islam 2021). The key target conditions for this suite of reviews are current SARS-CoV-2 infection, current COVID-19, and past SARS-CoV-2 infection. For current infection, the severity of the disease is of importance. SARS-CoV-2 infection can be asymptomatic (no symptoms); mild or moderate (symptoms such as fever, cough, loss of smell (anosmia) or taste (ageusia), aches, lethargy but without di iculty breathing at rest); severe (symptoms with breathlessness and increased respiratory rate indicative of pneumonia and oxygen need); or critical (requiring intensive support due to severe acute respiratory syndrome (SARS) or acute respiratory distress syndrome (ARDS), shock or other organ dysfunction (NIH 2021) . People with COVID-19 pneumonia (severe or critical disease) require di erent patient management, which makes it important to distinguish between them and mild or moderate disease. Thus, there are three target conditions for current infection: 1. SARS-CoV-2 infection (asymptomatic or symptomatic of any severity); 2. mild or moderate COVID-19 disease; 3. COVID-19 pneumonia (severe or critical). Here we summarise the evidence on signs and symptoms; as a result asymptomatic SARS-CoV-2 and past SARS-CoV-2 infection are out of scope for this review. Signs and symptoms are used in the initial diagnosis of suspected COVID-19 disease, and to identify people with COVID-19 pneumonia. Symptoms are what are experienced by patients, for example cough or nausea. Signs are obtained by clinical examination. Signs of COVID-19 examined in this review include lung sounds, blood pressure, blood oxygen level and heart rate. Key symptoms that have been associated with mild to moderate COVID-19 disease include: troublesome dry cough (for example, coughing more than usual over a one-hour period, or three or more coughing episodes in 24 hours), fever at examination greater than 37.8 °C, diarrhoea, headache, breathlessness on light exertion, muscle pain, fatigue, and loss of sense of smell and taste (Struyf 2021). Signs and symptoms indicating possible pneumonia (severe or critical disease) include breathlessness at rest, loss of appetite, confusion, pain or pressure in the chest, and temperature above 38°C . Important in the context of COVID-19 is that the pathway is multifaceted because it is designed to care for the diseased individual and to protect the community from further spread. Decisions about patient and isolation pathways for COVID-19 vary according to health services and settings, available resources, and stages of the epidemic. They will change over time if and when e ective treatments are identified and populations are increasingly vaccinated. The decision points between these pathways vary, but all include points at which knowledge of the accuracy of diagnostic information is needed to inform rational decision making. Prior testing will depend on whether people are being investigated for SARS-CoV-2 infection, mild COVID-19 or COVID-19 pneumonia. In this review on signs and symptoms, no prior tests are required because signs and symptoms are used in the initial diagnosis of suspected SARS-CoV-2 infection, and in identifying people with mild COVID-19 or COVID-19 pneumonia. Signs and symptoms are used as triage tests, that is, to rule out SARS-CoV-2 infection or COVID-19 disease, but also to identify people with possible COVID-19 who may require further testing, care escalation or isolation. We are producing a suite of Cochrane 'living systematic reviews', which will summarise evidence on the clinical accuracy of di erent tests and diagnostic features, grouped according to the present research questions and settings in the diagnosis of SARS-CoV-2 infection and COVID-19. Summary estimates of accuracy from these reviews will help inform diagnostic, screening, isolation, and patient-management decisions. New tests are being developed and evidence is emerging at an unprecedented rate during the COVID-19 pandemic. We will aim to update these reviews as o en as is feasible to ensure that they provide the most up-to-date evidence about test accuracy. These reviews are being produced rapidly to assist in providing a central resource of evidence to assist in the COVID-19 pandemic, summarising available evidence on the accuracy of the tests and presenting characteristics. Other Cochrane diagnostic test accuracy (DTA) reviews in the suite of reviews are addressing the following tests. It is essential to understand the accuracy of diagnostic features and tests to identify the best way they can be used in di erent settings to develop e ective diagnostic and management pathways. For example, the absence of a highly sensitive sign or symptom is good for ruling out COVID-19, while the presence of a sign or symptom with high specificity is good for ruling in COVID-19 ('red flag'). To assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID-19 clinics, has COVID-19. Where data are available, we investigated diagnostic accuracy (either by stratified analysis or meta-regression) according to: • days since symptom onset; • population (children, adults, older adults ≥ 65 years); • reference standard; • study design; • setting; and • risk of bias in participant selection (as scored using QUADAS-2) This review will no longer be updated in its current form. Objectives of any future updates of this review are: • to look at a broader approach involving a combination of signs and symptoms with other easy-to-obtain information, for example, point-of-care test results; • to perform the listed stratified analyses; • to explore seasonality; • to investigate people who require respiratory support or intensive care. In the first update of our review, we found 44 relevant studies with 26,884 participants. Prevalence of COVID-19 disease varied from 3% to 71% with a median of 21%. There were three studies from primary care settings (1824 participants), nine studies from outpatient testing centres (10,717 participants), 12 studies performed in hospital outpatient wards (5061 participants), seven studies in hospitalised patients (1048 participants), 10 studies in the emergency department (3173 participants), and three studies in which the setting was not specified (5061 participants). The studies did not clearly distinguish mild COVID-19 disease from COVID-19 pneumonia, so we presented the results for both conditions together. Fi een studies had a high risk of bias for selection of participants because inclusion in the studies depended on the applicable testing and referral protocols, which included many of the signs and symptoms under study in the review. Five studies only included participants with pneumonia on imaging, suggesting that this is a highly selected population. In an additional 12 studies, we were unable to assess the risk for selection bias. This makes it very di icult to judge the validity of the diagnostic accuracy of the signs and symptoms from these included studies. None of the studies presented any data on children separately, and only one focused specifically on older adults. We found data on 84 signs and symptoms. Results were highly variable across studies. Most had very low sensitivity and high specificity. Only cough (25 studies) and fever (7 studies The summary positive likelihood ratios of anosmia alone and anosmia or ageusia were 4.16 (95% CI 3.10 to 5.60) and 4.31 (95% CI 3.00 to 6.18) respectively, which is just below our arbitrary definition of a red flag, that is, a positive likelihood ratio of at least 5. The summary positive likelihood ratio of ageusia alone was 2.67 (95% CI 1.96 to 3.64). Only two studies assessed combinations of di erent signs and symptoms, mostly combining both fever and cough. These combinations had a specificity above 80%, but at the cost of very low sensitivity (< 30%). We concluded that the majority of individual signs and symptoms included in the review appear to have very poor diagnostic accuracy, although this should be interpreted in the context of selection bias and heterogeneity between studies. Based on the available data, neither absence nor presence of signs or symptoms are accurate enough to rule in or rule out disease. The presence of anosmia or ageusia may be useful as a red flag for the presence of COVID-19. The presence of fever or cough may, given their high sensitivities, be useful as a triage tool for further testing. We found more studies on symptoms in people with suspected COVID-19 that used prospective data collection, allowing for more reliable estimation of measures of diagnostic accuracy. Moreover, this update contains new studies on the diagnostic value of 29 di erent combinations of signs and symptoms. Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews who had already been admitted to hospital or who had presented to hospital settings with the intent to hospitalise. The lack of data on combinations of signs and symptoms was an important evidence gap. Only two studies presented data on such combinations. The few composite signs and symptoms that were presented in those studies had little added diagnostic value compared to single tests. Criteria for considering studies for this review We included published studies of all designs that produce estimates of sensitivity and specificity or provide data from which estimates can be computed. As of this update, we no longer included preprints. If no published version of previously included preprints could be found, we excluded these preprints. As of this review update, we only included single-gate, crosssectional designs (studies that recruit from a patient pathway before disease status has been ascertained). We included both studies that used retrospective data collection and studies that used prospective data collection, but the main findings of this review will be based on the prospective studies only, as retrospective studies tend to overestimate the diagnostic accuracy of the index tests (Rutjes 2006) . Studies had to have a minimum sample size of 10 participants. Studies recruiting people presenting with a clinical suspicion of SARS-CoV-2 infection, based on a symptomatic presentation, were eligible. At least 50% of the study population had to present with COVID-19-compatible symptoms. • All signs and symptoms, including: • signs such as oxygen saturation, measured by oximetry and blood pressure; • symptoms, such as fever or cough. To be eligible, studies had to identify at least one of: • mild or moderate COVID-19; • severe or critical COVID-19 (including COVID-19 pneumonia). Asymptomatic infection with SARS-CoV-2 is out of scope for this review, considering it is by definition not possible to detect this based on signs and symptoms. We anticipated that studies would use a range of reference standards. Although reverse transcription polymerase chain reaction (RT-PCR) is considered the best available test, due to rapidly evolving knowledge about the target conditions, multiple reference standards on their own as well as in combination have emerged. We expected to encounter cases defined by: • RT-PCR alone; • RT-PCR, clinical expertise, and imaging (for example, CT thorax); • repeated RT-PCR several days apart or from di erent samples; • plaque reduction neutralisation test (PRNT) or enzyme-linked immunosorbent assay (ELISA) tests; • information available at a subsequent time point; • World Health Organization (WHO) and other case definitions (see Appendix 1). This list is not exhaustive, and we recorded all reference standards encountered. The final search date for this version of the review is 10 June 2021. For this updated review, we used the University of Bern living search database as our primary register. This registry searches PubMed, Embase and preprint archives (medRxiv and bioRxiv) daily for COVID-19 research. The strategies to build the database can be found on the ISPM web site are described here ispmbern.github.io/ COVID-19/ and in Appendix 2. Due to the increased volume of literature a specific classifier was built for the review topic in Eppi reviewer. In brief, manual annotations of references on in-or exclusion from repeated retrieval dates from the previous versions of the review were partially used as training data and the remaining for validation and threshold for optimal recall determination. All references from the University of Bern living search database from 15 July 2020 till 10 June 2021 were run against the classifier and references labelled as potentially relevant were screened manually. See Appendix 3. We also checked our search results against two additional repositories of COVID-19 publications including: • the Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre) 'COVID-19: Living map of the evidence' (eppi.ioe.ac.uk/COVID19_MAP/covid_map_v4.html); • the Norwegian Institute of Public Health 'NIPH systematic and living map on COVID-19 evidence' (www.nornesk.no/ forskningskart/NIPH_diagnosisMap.html). Both of these repositories allow their contents to be filtered according to studies potentially relating to diagnosis, and both have agreed to provide us with updates of new diagnosis studies added. For this iteration of the review, we examined all diagnosis studies from both sources up to 10 June 2021. We did not apply any language restrictions. Pairs of review authors independently screened studies. We resolved disagreements by discussion with a third, experienced review author for initial title and abstract screening, and Cochrane Database of Systematic Reviews through discussion between three review authors for eligibility assessments. Pairs of review authors independently performed data extraction. We resolved disagreements by discussion between three review authors. We contacted study authors where we needed to clarify details or obtain missing information. Pairs of review authors independently assessed risk of bias and applicability concerns using the QUADAS-2 (Quality Assessment tool for Diagnostic Accuracy Studies) checklist, which was common to the suite of reviews but tailored to each particular review (Whiting 2011; Table 1 ). For this review, we excluded the questions on the nature of the samples as these were not relevant, and we added a question on who assessed the signs. We resolved disagreements by discussion between three review authors. We presented results of estimated sensitivity and specificity using paired forest plots in Review Manager 2020, and tables as appropriate. We considered tests to be useful in ruling out a serious infection in ambulatory care if their negative likelihood ratio (LR-) was lower than 0.20; conversely, we considered diagnostic tests useful as red flags for infections when their positive likelihood ratio (LR+) was 5.0 or higher (Jaeschke 1994; Van den Bruel 2010). We disaggregated data by study design, reporting results from prospective studies separately from studies that used a retrospective design, which we assessed as prone to high risk of bias (Rutjes 2006) . We focused on the results of prospective studies in this 2022 update. When interpreting the results, we made sure that the limitations of di erent study designs were carefully considered, using quality assessment and analysis. We estimated summary sensitivity and specificity using a bivariate random-e ects meta-analysis (Macaskill 2013). We undertook meta-analyses using the lme4 package (R 2020), implemented in MetaDTA (crsu.shinyapps.io/dta_ma/). We based the decision to pool data on the following criteria: clinically acceptable heterogeneity on visual inspection of the forest and ROC plots, the availability of at least five studies, and low risk of bias for participant selection. Sources of heterogeneity that we investigated if adequate data were available are listed in the Secondary objectives, either using stratification (where we believed it was inappropriate to combine studies) or through meta-regression models. In this version of the review, we have stratified by population (age group) and care setting. We aimed to undertake sensitivity analyses considering the impact of unpublished studies, but this was not possible in this version of the review due to the small number of studies in each metaanalysis. We aimed to publish lists of studies that we know exist but for which we have not managed to locate reports, and request information to include in updates of these reviews. However, at the time of writing this version of the review, we are unaware of unpublished studies. We have listed our key findings in Summary of findings 1 to determine the strength of evidence for each test and findings, and to highlight important gaps in the evidence. As we will explain in the discussion, this review will no longer be updated in its current form. Resources allowing, we will consider updating this review when su icient studies of high methodological quality become available examining the combination of signs and symptoms with other, easy-to-obtain information such as demographics, point-of-care test results, prior exposure to an infected person, and recent case detection rate. Another important outcome would be to investigate whether tests exist that identify people requiring respiratory support (SARS or ARDS) or intensive care. The first selection resulted in 23,683 potentially eligible articles. This included the 658 articles that we screened in our initial review and 7394 we screened in the first review update. A er screening 15,631 articles on title and abstract for this update, we excluded 15,348 articles, leaving 283 full-text articles to be assessed. We included 90 studies in this version of the review, 28 of which were included in the previous reviews. We excluded 16 studies from the previous review versions from this review because they were either preprints of which no published version was available at the time of our final search (n = 7), or because they were case-control studies (multi-gate designs, n = 9); see Characteristics of excluded studies. The reasons for excluding 221 articles are listed in the flow chart ( Figure 1 ; Moher 2009); reasons for excluding a selected number of studies (n = 143) that Cochrane readers might reasonably expect to find are also listed in Characteristics of excluded studies. The participants in Zimmerman 2020 and Rutten 2020a were a subset of those included in Chung 2021 and Rutten 2020b, respectively. We included all four studies in this review, but we used only the more complete data from Chung 2021 and Rutten 2020b. In the next section, we discuss the quality assessment of the 42 prospective studies only ( Participant selection was at high risk of bias in 12 out of 42 prospective studies. In seven studies (Alizadehsani 2021; Bhattacharya 2021; Brendish 2020; Buonafine 2020; Kalayjian 2020; Peyrony 2020; Romero-Gameros 2021), this was because a high level of preselection was used to decide whether RT-PCR testing was needed. For example, in Alizadehsani 2021, only patients with flu-like symptoms who were referred to the imaging department were included, leading to a preselection of individuals who are more likely to be infected with the SARS-CoV-2 virus and thus to a higher disease prevalence (38.5% in this example). Three studies (Bhattacharya 2021; Gilbert 2020; Just 2020), did not select a consecutive or random sample. Six studies (Leal 2020; Pivetta 2020; Romero-Gameros 2020; Saegerman 2021; Villerabel 2021; Wernhart 2020), excluded individuals while they were part of the study base. For most studies, testing was dependent on the local case definition and testing criteria that was in e ect at the time of the study, meaning all patients who were included in studies had already gone through a referral or selection filter. We rated all studies except seven (Bhattacharya 2021; Drager 2020; Fink 2021; Haehner 2020; Jeyashree 2021; Villerabel 2021; Wernhart 2020), as high risk of bias for the index tests because there was little to no detail on how, and by whom and when, the signs and symptoms were measured. However, concerns that the index tests, their performance or interpretation deviated from the research question were rated as low in all but one study (Leal 2020), where symptoms were ascertained via telephone assessment by a medical student. Olfactory symptoms were collected in di erent ways: interviews by telephone or in person using standardised questionnaires, online surveys, self-reporting at presentation, or systematic assessment by sta at enrolment without standardisation. The standardised questionnaires themselves are rarely reported, and are o en newly developed by each research team. We rated one study (Pivetta 2020), high risk of bias concerning the reference standard. They used either an RT-PCR or other information including clinical, lab data or imaging. All other studies used RT-PCR or CT scans, depending on the target condition, and we rated them low risk of bias, although some studies provided little detail on blinding. This lack of reporting of blinding of the reference standard did not result in a high risk of bias rating in studies with SARS-CoV-2 infection as the target condition, as we assumed that a lab-based RT-PCR result is not influenced by the index test results. Only one study (Alizadehsani 2021), was at unclear risk of bias because it was unclear whether the radiologist interpreting the CT scans was blinded to the index test results. , either because the timing of recording signs and symptoms and conduct of the reference standard was unclear, or because some patients received a second or third reference standard at unclear time points during hospital admission, or because participant records were deleted when containing missing data. We rated two studies (Leal 2020; Pivetta 2020), high risk of bias concerning patient flow as not all participants received the same reference standard. In summary, we rated 36 of the 42 studies as high risk of bias for the index tests because there was little or no detail on how, by whom and when, the signs and symptoms were measured. Participant selection had a high risk of bias in 12 of the 42 studies. Risk of bias was most o en rated low with regard to the implementation of the reference standard, and unclear with regard to flow and Library Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews timing. However, the applicability of the study findings to our review question did not o en give rise to substantial concerns. The main characteristics of all 42 prospective included studies are listed in Table 2 . Thirty-five studies were set in emergency departments or outpatient test centres ( Only one study assessed accuracy of signs and symptoms for the diagnosis of COVID-19 pneumonia (Alizadehsani 2021), the remaining studies had SARS-CoV-2 infection as the target condition. The distinction between these two target conditions was not always very clear though, and a degree of overlap is to be assumed and we therefore present the results for both conditions together. All but two studies (Alizadehsani 2021; Drager 2020) used RT-PCR testing as reference standard, with some variation in the samples that were used. Alizadehsani 2021 used CT scanning for the diagnosis of COVID-19 pneumonia. Drager 2020 did not specify the reference standard. There were 52,608 participants in all 42 prospective studies, the median number of participants was 553. Prevalence varied from 3.7% to 60.6% with a median of 27.4%. We found data on 96 symptoms, which fall into seven di erent categories,that is, systemic signs and symptoms, upper respiratory, lower respiratory, olfactory, gastro-intestinal, cardiovascular and multivariable combinations of signs or symptoms. Evidence on individual signs as diagnostic tests was rarely reported, so this review reports mainly on the diagnostic value of symptoms. Results for the prospective cross-sectional studies are presented in forest plots ( Figure 18 ; Figure 19 ). Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews Figure 19 . Summary ROC plot of anosmia by risk of bias concerning participant selection. Summary points and their 95% confidence regions are shown for high and low risk of bias only. The study points (symbols) were scaled according to the sample size We conducted meta-analyses for 13 symptoms at presentation (fever, dyspnoea, cough, diarrhoea, sore throat, fatigue, rhinorrhoea, headache, anosmia, anosmia or ageusia, ageusia, myalgia, chills/shivers). The ranges and summary estimates of the sensitivity and specificity of the 13 index tests are listed below, ordered by decreasing number of studies included. Summary estimates of test accuracy are listed in additional Table 3 . They are based on bivariate meta-analyses of prospective studies with low risk of bias for participant selection. Cough was the only index test with a summary sensitivity above 50%. Its summary specificity was 45.4% (Table 3) . Summary specificity was above 90% for anosmia, ageusia and for the presence of anosmia or ageusia (Table 3 ). However, their summary sensitivity was low (maximum 39.2% for anosmia or ageusia). The summary positive likelihood ratios (LRs+) of anosmia as a single test or in combination with ageusia ('anosmia or ageusia') was just below our predefined cut-o of 5 for a useful red flag (4.55, 95% CI 3.46 to 5.97) and 4.99, 95% CI 3.22 to 7.75) respectively). The summary negative likelihood ratios (LRs-) were too high to make any of the reported tests useful for ruling out COVID-19. In other words, the absence of the above-mentioned symptoms or signs does not necessarily imply the absence of COVID-19. Twenty-four studies assessed combinations of di erent signs and symptoms ( Figure 10 ; Figure 16 ). In total, 29 di erent combinations were assessed, of which only six were assessed by more than one study. In addition to anosmia or ageusia (see pooled results), some other paired combinations of symptoms were investigated ( Figure 10 ; Figure 16 ). The following combinations showed a sensitivity of more than 50% in at least one study. • Anosmia or hyposmia (3 studies): sensitivity from 20% to 50% and specificity from 81% to 98% • Myalgia or arthralgia (3 studies): sensitivity from 29% to 58% and specificity from 61% to 79% • Cough or dyspnoea (1 study): sensitivity of 83%, specificity of 20% • Myalgia and fatigue (1 study): sensitivity of 60%, specificity of 33% Positivity rates (presence of the symptom in the study population) of signs and symptoms depend on prevalence of COVID-19 and population characteristics, especially preselection. As a result, positivity rates were highly variable. In studies with prevalence less than 10%, suggesting little preselection had taken place, positivity rates for fever were between 1.2% and 69.3% (24.7% average), for cough between 12.7% and 83.7% (54.9% average), for anosmia between 2.5% and 13.8% (7.1% average), for ageusia (2 studies) between 2.8% and 19.6% (11.2% average), and for anosmia or ageusia (1 study) 4.3%. Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews Three prospective studies were performed specifically in children (Olivar Lopez 2020; Pokorska-Śpiewak 2021; Yonker 2020), and two overlapping studies in older people living in a nursing home (Rutten 2020a; Rutten 2020b). All other studies were either performed in adults or in individuals of all ages. Meta-analysis of data in children or older adults was impossible due to the limited number of studies in these age groups. We therefore limited ourselves to descriptive analyses. All forest plots ( Cochrane Database of Systematic Reviews In children, compared to the adult population, the di erences in diagnostic accuracy depended strongly on the type of symptom. For example, the sensitivity of fever in children ranged from 47% to 62%, which is higher than the overall summary result for all ages (29%). The specificity of fever in children ranged from 30% to 53%, which is lower than the overall summary result (82.2%). In contrast, we observed lower sensitivity and higher specificity for fatigue, headache and myalgia in children than in the population as a whole. The results for sore throat, rhinorrhoea, cough, dyspnoea and diarrhoea were comparable with the overall population. Olfactory symptoms were rarely investigated in children. One study (Yonker 2020), investigated the diagnostic value of dysgeusia, observing similar accuracy to in the adult population. In older adults living in a nursing home, most symptoms showed sensitivities and specificities that were comparable to the overall summary results (Rutten 2020b). The sensitivity of fever appeared to be higher in older people, but this may be due to a strong preselection based on the presence of fever. The summary estimates of fever, cough and anosmia from prospective studies that had either a low or a high risk of bias concerning participant selection are presented in ROC curves for comparison ( Figure 17 ; Figure 18 ; Figure 19 ). We observed the largest di erence between both summary estimates for fever. The di erences between the summary estimates between low and high risk of bias concerning participant selection were less pronounced for cough and for anosmia. Stratification according to setting did not explain the observed heterogeneity in diagnostic accuracy. To further illustrate the ability of a test to either rule in or rule out COVID-19, we constructed dumbbell plots showing pre-and post-test probabilities for anosmia, anosmia or ageusia, fever and cough by age group in each prospective cross-sectional study with a low risk of bias rating for selection of participants (Haehner 2020; Jeyashree 2021; Kempker 2020; Maechler 2020; Trubiano Cochrane Database of Systematic Reviews 2020; Tudrej 2020; Van Loon 2021; see Figure 20 ; Figure 21 ; Figure 22 ). For each test, we have plotted the pre-test probability, which is the prevalence of COVID-19 disease in the study (blue dot). The probability of having COVID-19 disease a er testing (posttest probability) then changes depending on a positive test result (red dot marked +) or a negative test result (green dot marked -). The plot shows that the presence of anosmia, for example, increased the probability of COVID-19 in all seven studies. Its absence slightly decreased the probability of COVID-19 in three studies (Kempker 2020; Tudrej 2020; Van Loon 2021), and in the four other studies there was not much di erence between preand post-test probability (Haehner 2020; Jeyashree 2021; Maechler 2020; Trubiano 2020). Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews This is the second update of a living systematic review of signs and symptoms for the diagnosis of COVID-19 in an outpatient setting. For the first time, this update provided a large number of cross-sectional studies using prospective data collection, leading to results that are more reliable than those presented in previous versions of this review. Nevertheless, considerable heterogeneity between study results remains a concern. Our main conclusion remains unchanged: most individual symptoms appear to have poor diagnostic accuracy. Neither absence nor presence of symptoms are accurate enough to rule in or rule out the disease. The presence of anosmia or ageusia may be useful as a red flag for the presence of COVID-19. Some combinations of signs and symptoms may be useful as a tool to triage patients for further testing. This review update identified more studies on combinations of signs and symptoms, but only six out of 29 di erent combinations were assessed by more than one study. Some combinations may be useful as a triage tool. For example, in a cohort with a disease prevalence (pre-test probability) of 5%, the presence of either anosmia or ageusia would increase the post-test probability of the presence of COVID-19 to 21%. The combination of signs and symptoms with other readily available information may prove useful in safely ruling out COVID-19. The multivariable prediction score with the highest sensitivity (90.0%) combined gender, being a healthcare worker, recent contact with a COVID-19 case, recent travel, 0.5 times the recent local case detection rate, the presence of rhinorrhoea, cough or dyspnoea, and a combination of age and the presence of fever (SCRiPS Score, Van Walraven 2021). This type of score may be especially useful to safely rule out COVID-19, because it achieves a sensitivity that cannot be obtained by combining symptoms alone. For example, using this score, a 35-year old female healthcare worker without chest symptoms but with fever and rhinorrhoea, Cochrane Database of Systematic Reviews who did not have contact with a COVID-19 case recently and who did not travel recently, would have a 1% chance of having COVID-19 if the local recent case detection rate was 5%. An 85-year old man with fever, without any other symptom, who did not travel recently but who did have a recent contact with a COVID-19 case, would have a 46% chance of having COVID-19 at the same local recent case detection rate of 5%. Of course, such a score should ideally be validated externally in other populations before being applied in practice. The presence of upper respiratory symptoms such as a sore throat, rhinorrhoea or coryza, increases the probability of having an infectious disease other than COVID-19. In a hypothetical cohort of 1000 individuals, at a COVID-19 prevalence of 5%, 16 people with a sore throat would have COVID-19 and there would be 362 people with a sore throat without COVID-19 (false positives). Not using sore throat as an indication to test wouldn't necessarily lead to 16 people with COVID-19 being missed, as some of those individuals would present with other symptoms that would prompt further testing. We found similar figures for rhinorrhoea and coryza. There is currently no evidence to support further testing in all individuals presenting only with upper respiratory symptoms. Selection bias is present when selective and non-random inclusion and exclusion of patients apply and the resulting association between exposure and outcome (here the accuracy of the test) di ers in the selected study population compared to the eligible study population (Rutjes 2006) . For the diagnosis of COVID-19, rapidly and constantly changing and widely variable test criteria have influenced who was referred for testing and who was not, both for the presence of infection and disease. Selection in the study of only a fraction of the eligible patients can result in a biased estimate of the true accuracy of the index test when measured against the reference standard and true disease status. Gri ith 2020 have reported on the problematic presence of collider stratification bias in the published studies on COVID-19. Appropriate sampling strategies need to be applied to avoid conclusions of spurious relationships, more specific in our case the biased accuracy estimates of signs and symptoms for the diagnosis of both SARS-CoV-2 infection and COVID-19 disease. Selection of patients based on the presence of specific preset symptoms, such as fever and cough, leads to biased associations between these symptoms and to disease and diagnostic accuracy estimates that di er from their true values. The example of collider bias for cough is illustrated in Figure 30 . Grouping studies by diagnostic criteria for selection might clarify this issue, but studies do not clearly describe them, with study authors referring to the guidelines in general that were applicable at the time. Another form of selection bias is spectrum bias, where the patients included in the studies do not reflect the patient spectrum the index test will be applied to. The inclusion of hospitalised patients can lead to such a bias, when the distribution of signs and symptoms di er in these patients and assessment with the reference standard is di erential. In addition, the distribution and severity of Cochrane Database of Systematic Reviews alternative diagnoses may be di erent in hospitalised populations than in patients presenting to ambulatory care settings. By focusing on prospective studies, spectrum bias was minimised in this review update, as all but two studies, that were performed in a mix of inand outpatients from paediatric hospitals (Pokorska-Śpiewak 2021; Yonker 2020), were conducted in an outpatient setting. The observed better sensitivity for cough (and lower specificity) compared to other index tests is unsurprising considering cough was a key feature of COVID-19 that was used in selecting patients for further testing in included studies. As a result, a large proportion of patients in these studies would have a cough, both cases and non-cases. The same applies to fever, for which we observed a large heterogeneity between studies. Some of this heterogeneity was reduced by selecting only studies with a low risk of bias in participant selection for the analyses, but a residual selection bias remained due to preselection based on the presence of fever. The way fever was determined (measured at presentation or selfreported by the patient) and the use of di erent cut-o levels for fever also contributed to this residual heterogeneity. Strengths of our review are the systematic and broad search performed to include all possible studies, to gather the largest number of peer-reviewed studies available at this point. Exclusion of retrospective studies, the largest number of the published cohorts of patients with COVID-19, from the data analyses limits the available data but improves the quality of the evidence. The greatest weakness of the review is the risk of selection bias, as discussed above, with many studies selecting their participants based on the presence of fever or respiratory symptoms. Since individuals may or may not be tested on the basis of symptomatic presentation, this limitation is di icult to avoid completely. Although we included all studies published until June 2021, all studies reported data from 2020 and over 90% of these data were collected in the first half of 2020. Consequently, no studies reported signs or symptoms of specific viral variants. We need to assess multiple variables for their possible confounding e ect on the summary estimates. Possible confounders include the presence of other respiratory pathogens (seasonality), the phase of the epidemic, exposure to high-versus low-prevalence setting, high or low exposure risk, comorbidity of the participants, or time since infection. Seasonality may influence specificity, because alternative diagnoses such as influenza or other respiratory viruses are more prevalent in winter, leading to more non-COVID-19 patients displaying symptoms such as cough or fever, decreasing specificity. In this version of the review, most studies were conducted during the winter or early spring seasons, suggesting this may still have been at play. However, social distancing policies have shortened this year's influenza season in several countries (who.int/influenza/surveillance_monitoring/updates), which may have led to higher specificity for signs and symptoms than what we may expect in the next influenza season. In future updates of the review, we will explore seasonality e ects if data allow. As for time since onset, given that the moment of infection is more likely than not an unrecognisable and unmeasurable variable, time since onset of symptoms can be used as a proxy. Reporting of studies, with presentation of the 2x2 table stratified by time since onset of disease, is informative and might have the potential to increase accuracy of the signs and symptoms and their diagnostic di erential potential. In comparison with previous updates, in which many studies included patients who had already been admitted to hospital or who presented to hospital settings with the intent to hospitalise, selection bias was reduced by focusing on prospective studies only. These studies were primarily conducted in outpatient settings, improving the applicability of our findings in comparison with previous review versions. This review identified only three studies in children. The di erences in diagnostic accuracy with adults depended on the type of symptom. The sensitivity of fever in children was higher than the summary estimate across all ages and its specificity was lower. Fever was much more common in children than in adults (higher positivity rate), but o en indicated the presence of an infectious disease other than COVID-19 (high proportion of false positives). In contrast, we observed lower sensitivity and higher specificity for fatigue, headache and myalgia in children than in the population as a whole. Olfactory symptoms were investigated by very few studies in children. Children have been disproportionally underrepresented in studies concerning the diagnosis of SARS-CoV-2 infection. Their absence seems related to the general mild presentation of the disease in the paediatric population and even more frequently the complete asymptomatic course. The full scope of disease presentation in children is however not known. It is important to identify signs and symptoms that can be used to clinically assess children with suspected SARS-CoV-2 infection, especially because non-specific presentations and fever without a source are already common in this age group. Children present as a heterogeneous group, having separate data for neonates, young infants, toddlers, school-aged children and adolescents is of value. Misclassification of children both at their presentation to the healthcare system and in the short term, where children will be asked to remain in quarantine when they present with predefined, but not yet evidence-based symptoms needs to be avoided to decrease the possible damage done to children's health. Another important patient group that has been neglected in the literature is older adults. They are most at risk of a negative outcome of SARS-CoV-2 infection, especially mortality but also intensive care support. In this version of the review, only two overlapping studies (1 dataset) focused on adults aged 65 years or older. All other studies included adults of all ages and did not present results separately for the older age groups. The lack of a solid evidence base for the diagnosis of COVID-19 in older adults adds to the di iculty in diagnosing serious infections in this age group, in whom other serious infections such as bacterial pneumonia or urinary sepsis also tend to lead to non-specific presentations. Studies specifically focusing on older adults or children may also enable us to estimate any di erence in the diagnostic accuracy of signs and symptoms within these age groups. Given the distinct biological characteristics of children versus younger and versus older adults, these accuracy estimates are likely to be di erent in di erent age groups. The current presentation of overall summary estimates may therefore prove too simplistic. The presence of some signs and symptoms may increase the probability of COVID-19 to an extent that is clinically relevant. Within the context of selection bias in most of the studies in this review, the presence of fever, cough, or anosmia/ageusia should be a reason for further testing for COVID-19. Other symptoms, such as sore throat, rhinorrhoea or coryza, increase the probability of COVID-19 to a much lesser extent. Selecting patients for reverse transcription polymerase chain reaction (RT-PCR) testing based on these minor symptoms will result in large numbers of people who need to be tested and low positivity rates, making such testing strategies more cumbersome, expensive and less e icient. However, if the main goal of a country's testing strategy remains to detect as many SARS-CoV-2-positive individuals as possible, denying further testing to people based on the absence of major (and even minor) symptoms will result in many missed cases. In short, the diagnostic accuracy of symptoms for COVID-19 is moderate to low and any testing strategy using symptoms as selection mechanism will result in both large numbers of missed cases and large numbers of people requiring testing. Which one of these is minimised, is determined by the goal of COVID-19 testing strategies, that is, controlling the epidemic by isolating every possible case versus identifying those with clinically important disease so that they can be monitored or treated, or both, to optimise their prognosis. The former will require a testing strategy that uses very few symptoms as entry criterion for testing, the latter could focus on more specific symptoms such as fever and anosmia. Our review update reflects the need for a broader diagnostic approach than looking at signs or symptoms alone. Combinations with other, easy-to-obtain information such as patient demographics, the local case detection rate, recent contact with a SARS-CoV-2-positive patient, travel history of the patient, pointof-care test results, vaccination status, and others, may help safely rule out COVID-19 and should be investigated further. Vaccination leads to a reduced rate of asymptomatic infections (Tande 2022). Whether it also alters the clinical presentation of symptomatic COVID-19 patients is unclear at this time. New variants of the virus might also change the clinical presentation. Given the speed with which these variants emerge, it is di icult to provide up-to-date information from a systematic review regarding the diagnostic value of symptoms for COVID-19. This review will therefore no longer be updated in its current form. Resources allowing, we will consider updating this review when su icient studies of high methodological quality examining the combination of signs and symptoms with other clinically relevant information such as contact or travel history, or the local recent case detection rate become available. Another important outcome for future updates would be to investigate whether tests exist that identify people requiring respiratory support (SARS or ARDS) or intensive care. Studies should report the definition of signs and symptoms more clearly, how they were measured, by whom and when. The measurement of key symptoms such as anosmia and ageusia could benefit from standardisation, including the severity and nature of the loss of smell or taste. Yet such standardisation should not be overly complicated as signs and symptoms will typically be used by frontline clinicians who will incorporate these in their more holistic assessment of the patient, which includes more than just diagnosis of COVID-19. Future studies should also include a broader spectrum of patients with studies in the primary healthcare setting to properly evaluate the diagnostic accuracy of signs and symptoms in this setting. Studies aimed at screening for SARS-CoV-2 infections should also be included, as an increased need for screening is to be expected with the relaxation of quarantine measures. Finally, data are needed on specific patient groups with comorbidities with a higher risk of complications or serious illness and a greater impact of missing early diagnosis of SARS-CoV-2 infection, and the paediatric and elderly population should be added. We would like to recommend that authors adhere to the STARD guidelines when reporting new studies on this topic (Bossuyt 2015). Members of the Cochrane COVID-19 Diagnostic Test Accuracy Review Group include the following. Cochrane Database of Systematic Reviews results for SARS-CoV-2 in a population with higher testing rates than among previously published cohorts Design: multicenter cross-sectional cohort study, retrospective data collection Recruitment: all patients tested for SARSCoV-2 in the UHealth system during the study period were eligible for this cohort study. For a random subset of patients tested during 10-31 March 2020, symptom data were manually extracted from medical records from 24 h before and 24 h after SARS-CoV-2 testing. Medical records were selected to include at least 20% of patients tested on each day, for a total of 1821 patients. Inclusion criteria: all patients tested for SARS-CoV-2 in the UHealth system during the study period. Test eligibility required at least 1 of the following symptoms -cough, fever, shortness of breath, or a high risk of exposure given recent travel or contact with a person who tested positive. Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Unclear Ahmed 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Unclear If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Aldobyany 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Alizadehsani 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Allegorico 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Cochrane Database of Systematic Reviews Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Cochrane Database of Systematic Reviews Did the study avoid inappropriate inclusions? Unclear Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Bouzid 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Unclear Bouzid 2020 (Continued) Study characteristics Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to examine and compare the clinical characteristics, symptoms, and outcomes of adult patients presenting to the ED or Acute Medicine Unit (AMU), testing positive and negative for COV-ID-19 Design: cross-sectional cohort study, prospective data collection from a large, controlled, non-randomised trial of molecular POC testing vs laboratory RT-PCR for SARS-CoV-2 Recruitment: all consecutive patients presenting to the ED or AMU or other admissions area of Southampton, with an acute respiratory illness or otherwise clinically suspected of having COVID-19 (= all patients included in the CoV-19 POC trial) Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Yes Brendish 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 Could the patient flow have introduced bias? Brendish 2020 (Continued) Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Buonafine 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Chan 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 Cochrane Database of Systematic Reviews Are there concerns that the index test, its conduct, or interpretation differ from the review question? DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Unclear Did all patients receive the same reference standard? Were all patients included in the analysis? Yes Could the patient flow have introduced bias? Cheng 2020 (Continued) Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Chua 2020 (Continued) Cochrane Database of Systematic Reviews Were the index test results interpreted without knowledge of the results of the reference standard? Unclear If a threshold was used, was it pre-specified? No Could the conduct or interpretation of the index test have introduced bias? Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Inclusion criteria: all HCW tested for SARS-CoV-2, based on symptom-based triage ("symptoms concerning for COVID-19 infection" Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No High risk Low concern Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Low concern Unclear Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Cli ord 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( High risk High Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Unclear Cunarro-Lopez 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Drager 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Feng 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Low concern Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Yes High risk Design: cross-sectional cohort study, retrospective data collection Recruitment: every paediatric patient (ages 0-15 years) that had undergone a RT-PCR test for detection of SARS-CoV-2 in a nasopharyngeal sample due to suspected infection was invited for a serology test and interview, setting unclear Sample size: n = 126 (33 cases) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Inclusion criteria: patients aged 0-15 years who underwent RT-PCR test due to clinical suspicion of SARS-CoV-2 during the period under study whose parents/legal guardians provided consent and did not meet any of the exclusion criteria Unclear risk Unclear Were the index test results interpreted without knowledge of the results of the reference standard? Unclear If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Fink 2021 (Continued) Inclusion criteria: all consecutive patients suspected of SARS-CoV-2 infection and directed to the triage centres located close to the EDs and subjected to SARS-CoV-2 testing; suspicion = respiratory symptoms and/or fever in a healthcare provider, an immunosuppressed patient or a nursing home resident, and all patients who required admission to the hospital Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Haehner 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Unclear If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease) -to evaluate the SARS-CoV-2-positive ratio among mildly ill patients in Tokyo, Japan, their characteristics, the Ministry of Health, Labour and Welfare criteria, and to identify better criteria Design: cross-sectional cohort study, retrospective data collection Recruitment: patients who underwent SARS-CoV-2 PCR testing at the National Center for Global Health and Medicine in Tokyo (= outpatient screening centre) Inclusion criteria: those who met ≥ 1 of the following criteria were eligible: patients who have fever or symptoms (e.g. respiratory, fatigue, headache, myalgia); patients who had exposure to COVID-19 patient; patients who did not meet 1) or 2) but referred by another physician due to possible exposure to COVID-19 patient or travel history. High risk Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Ide 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Ishii 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Cochrane Database of Systematic Reviews Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Just 2020 (Continued) Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Inclusion criteria: patients < 18 years with a positive PCR test or were tested for being in a high-risk group (close contact with a case or in an outbreak) Exclusion criteria: second tests or patients tested prior to 13 April 2020. Children who were tested for symptoms and were negative, were not contacted for the symptom questionnaire. High risk Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? No If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Langer 2020 (Continued) Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Lazzerini 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Unclear Did all patients receive the same reference standard? Were all patients included in the analysis? Yes Unclear risk Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to describe the clinical features predictive for SARS-CoV-2 infection in primary care Recruitment: residents of the municipality aged ≥ 12 years with suspected COV-ID-19 symptoms were encouraged to contact the dedicated platform via the website or phone. They were invited to complete an initial screening questionnaire. Participents were then called by a medical student to complete a risk assessment. Sample size: n = 1583 (444 cases (only the PCR-positive patients) Inclusion criteria: patients meeting the suspected COVID-19 case definition (having at least 2 of the following symptoms: fever, cough, sore throat, coryza or change in/loss of smell (anosmia); or 1 of these symptoms plus at least 2 other symptoms consistent with COVID-19 Leal 2020 Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Yes High risk Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Unclear Did all patients receive the same reference standard? Yes Were all patients included in the analysis? No Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Maechler 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to evaluate safety and feasibility of low-threshold testing process; to identify clinical predictors for severe acute COVID-19 Design: cross-sectional cohort study, prospective data collection Recruitment: all patients presenting at the test centre with respiratory symptoms (such as shortness of breath), other flu-like symptoms (fever, sore throat, cough) and self-reported exposure to COVID-19 Sample size: n = 4815 (572 cases) Inclusion criteria: all patients presenting at the test centre with respiratory symptoms, flu-like symptoms and self-reported exposure to COVID-19 Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Mansella 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the index test, its conduct, or interpretation differ from the review question? DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Unclear Did all patients receive the same reference standard? Yes Could the patient flow have introduced bias? Low risk Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to ascertain the effectiveness of the screening strategy and provide insight for early diagnosis of COVID-19 Design: multicenter, retrospective, observational cohort study Recruitment: all patients visiting the fever clinics within the study period Sample size: n = 1004 (cases = 188) Inclusion criteria: all patients visiting the fever clinics within the study period. Patients with fever (body temperature > 37.5 °C), or patients with pulmonary symptoms and epidemiological exposure history were requested to visit the fever clinics. All patients visiting the fever clinics during the study period were included. Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Mao 2020 (Continued) High risk Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Library Trusted evidence. Informed decisions. Better health. Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? No Were all patients included in the analysis? No Low risk Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to assess the utility of self-reported symptoms in identifying positive COV-ID-19 cases among predominantly healthy young adults in a military setting Design: cross-sectional cohort study, retrospective data collection Recruitment: all individuals who were deemed eligible for COVID-19 testing by the Israel Defence Forces COVID Centre, including those voluntarily calling to report symptoms, those actively addressed following epidemiological investigation Inclusion criteria: all individuals who were deemed eligible for COVID-19 testing by the Israel Defence Forces COVID Centre (suspicious symptoms, those quarantined), including those voluntarily calling to report symptoms, those actively addressed following epidemiological investigation Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Nitecki 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the index test, its conduct, or interpretation differ from the review question? DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Unclear Did all patients receive the same reference standard? Yes Were all patients included in the analysis? No Unclear risk Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to determine the clinical and epidemiological predictors of a positive SARS-CoV-2 test result and the requirement for intensive respiratory support Design: cross-sectional cohort study, prospective data collection Inclusion criteria: all adults who met the testing criteria for COV-ID-19 and who presented at the ED Exclusion criteria: patients who attended the screening clinic and did not present for medical assessment in the ED (no clinical data available) Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing High risk Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Inclusion criteria: patients with at least 2 of the following symptoms: fever/feverish feeling, cough and shortness of breath -later on (from 10 April 2020) patients with atypical symptoms were added. Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Rutten 2020a (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Shah 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Cochrane Database of Systematic Reviews Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Could the patient flow have introduced bias? Sun 2020 (Continued) Study characteristics Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to describe the differences in clinical presentation between COVID-19 and other respiratory viruses and to determine independently associated clinical features with COVID-19 Design: cross-sectional multicenter cohort study, retrospective data collection Recruitment: all patients who fulfilled the hospital's COVID-19 suspect criteria were admitted and tested for both SARS-CoV-2 and non-SARS-CoV-2 respiratory viruses. The hospital's suspect criteria were based on a combination of clinical symptoms, and a constant changing criteria for a history of (international) travel based on the current epidemiological risks Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Tan 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Design: cross-sectional cohort, retrospective data collection Recruitment: all patients presenting to 1 of 2 EDs, located at an urban teaching hospital, and academic quaternary medical centre, within the same healthcare system who had targeted testing based on clinician's decision during the initial 10 days of test availability Sample size: n = 283 (29 cases) Inclusion criteria: • patients presenting with symptoms related to COVID-19 infection (fever and cough or shortness of breath) • travel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan and South Korea) or • risk factors for infection complications (including age or comorbid conditions) or • the patient was a HCW who could potentially expose others at risk and clinician made decision for testing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? DOMAIN 3: Reference Standard Tolia 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Could the selection of patients have introduced bias? Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Yes If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Van Walraven 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Vieceli 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the index test, its conduct, or interpretation differ from the review question? Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Inclusion criteria: all HCW or outpatients with symptoms or with close contact with an index case presenting at the screening facility Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Yes Were all patients included in the analysis? Yes Wei 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Yes Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Wernhart 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Xie 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Yombi 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Unclear If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Low concern DOMAIN 4: Flow and Timing Are there concerns that the included patients and setting do not match the review question? Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard? Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Yes Zhu 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Are there concerns that the included patients and setting do not match the review question? Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Unclear Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Zimmerman 2020 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Presence of symptoms including rhinorrhoea; fever symptoms including rigor, chills, perceived fever, or documented fever at home or at the screening clinic; cough; and shortness of breath. Any infection risk factor including close contact with a person with known or presumed COVID-19 disease or recent travel outside of Canada. In the absence of these indications, HCWs were included if they had symptoms of sore throat, sputum production, or rhinorrhoea. As the evidence base evolves over the course of the pandemic, we have made some adjustments to our original approach with the following changes between earlier versions of the review and this second update: • Clarification regarding inclusion criteria: suspicion of infection was interpreted as: clinical suspicion of SARS-CoV-2 infection based on a symptomatic presentation. At least 50% of the study population had to present with COVID-19 compatible symptoms. • Both studies using a retrospective and a prospective data collection were included, but the main findings of this review were based on the prospective studies only, as retrospective studies tend to overestimate the diagnostic accuracy of the index tests. • Preprints that were included in previous versions of the review were now excluded (unless they were published in the meantime), and they were no longer included from this update onwards. Consequently, this second review update does not contain any preprints. Records from preprint archives were no longer evaluated for eligible studies because of an increase in COVID-19 study references from recommended diagnostic test accuracy sources (MEDLINE and Embase). For the baseline review, preprint archives were essential to identify emerging evidence; but for the second update, it was no longer necessary to search these sources. • Search sources included in the protocol and the previous version of this review, the Cochrane COVID-19 Study Register and the CDC Database of COVID-19 Research Articles, were not included in this version as the single source from the University of Bern living search database proved more e icient to process as it did not involve manual e ort to deduplicate. • We did not set out to identify any ongoing studies for this 2022 review version since the review will no longer be updated in its current form (see Objectives). 495 participants: sensitivity range 6% to 64% (summary 37.6%, 95% CI 23.4% to 54.3%) 545 participants: sensitivity range 6% to 73% (summary 23.3%, 95% CI 16.4% to 31.9%) 702 participants: sensitivity range 20% to 82% (summary 62.4%, 95% CI 50.6% to 72.9%) 669 participants: sensitivity range 6% to 64% (summary 18.5%, 95% CI 15.7% to 21.6%); specificity range 69% to 93% 7967 participants: sensitivity range 0% to 82% (summary 40.2%, 95% CI 19.4% to 65.1%); specificity range 32% to 97% (summary 73.6%, 95% CI 48 972 participants: sensitivity range 12% to 64% (summary 30.3%, 95% CI 18 899 participants: sensitivity range 0% to 78% (summary 35.8%, 95% CI 17.2% to 60.0%) seven studies, 9456 participants: sensitivity range 9% to 65% • Anosmia or ageusia, six studies, 6142 participants: sensitivity range 12% to six studies, 2684 participants: sensitivity range 0% to 70% 472 participants: sensitivity range 8% to 81% (summary 25.3%, 95% CI 15.1% to 39.3%); specificity range 64% to 98% five studies, 8644 participants: sensitivity range 2% to 53% (summary 23.2%, 95% CI 10.6% to 43.3%) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has Symptoms and severity: not specified, mostly symptomatic presentation (mild to moderate severity) Demographics: age: overall 42 years M%/F% Exposure history: confirmed contact with SARS-CoV-2 infected person: 43.8% severity: mild to moderate severity, high prevalence (> 50%) of symptoms such as cough, asthenia, myalgia and headache; oxygen saturation < 93% in 11% of cases and 4% of controls Demographics: age: controls mean 42.8 years, cases mean 48 Exposure history: not specified years; symptoms concerning for COVID-19 or admitted for acute symptoms related to COVID-19 or MIS-C; informed consent, and if appropriate, assent,were verbally obtained by the patients or parent/guardian Exclusion criteria: none specified Patient characteristics and setting Facility cases: positive RT-PCR for SARS-CoV-2 Facility controls: negative RT-PCR for SARS-CoV-2 Country Symptoms and severity: asymptomatic to mild symptoms to MIS-C Demographics: mean age: cases 12.7 years Exposure history: household exposures cases: mother: 40.8%, father: 26.5%, sibling: 18.4%, other: 18 Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has Copyright © 2022 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration SARS-CoV-2 infection • RS: SARS-CoV-2 RT-PCR test ]), the National Institute of Allergy and Infectious Disease (K24AI141036 to I.B.), the Centers for Disease Control and Prevention Adolescent or adult: fever or suspected respiratory infection, plus one of the following: respiratory rate higher than 30 breaths per minute; severe respiratory distress; or oxygen saturation (SpO 2 ) 93% or less on room air. Child with cough or di iculty in breathing, plus at least one of the following: central cyanosis or SpO 2 less than 90% signs of pneumonia with a general danger sign: inability to breastfeed or drink, lethargy or unconsciousness Other signs of pneumonia may be present: chest indrawing, fast breathing (in breaths per minute): aged under 2 months: 60 or higher aged 2 to 11 months: 50 or higher X-ray, computed tomography (CT) scan, or lung ultrasound): bilateral opacities, not fully explained by volume overload, lobar or lung collapse Origin of pulmonary infiltrates: respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (for example, echocardiography) to exclude hydrostatic cause of infiltrates/oedema if no risk factor present 200 mmHg less than ratio of arterial oxygen partial pressure/fractional inspired oxygen (PaO 2 /FiO 2 ) 300 mmHg or less (with positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) 5 cmH 2 O, or more • moderate ARDS: 100 mmHg < PaO 2 /FiO 2 ≤ 200 mmHg (with PEEP ≥ 5 cmH 2 O, or non-ventilated) PaO 2 /FiO 2 ≤ 100 mmHg (with PEEP ≥ 5 cm H 2 O, or non-ventilated) • when PaO 2 is not available, SpO 2 /FiO 2 ≤ 315 mmHg suggests ARDS Use PaO 2 -based metric when available. If PaO 2 not available, wean FiO 2 to maintain SpO 2 ≤ 97% to calculate OSI or SpO 2 /FiO 2 ratio: • bilevel (non-invasive ventilation or CPAP) ≥ 5 cm H 2 O via full-face mask: PaO 2 /FiO 2 ≤ 300 mmHg or SpO 2 /FiO 2 ≤ 264 The Newscast (Radio 4). Five opinion pieces in Guardian, unHerd and the BMJ. Numerous television, radio and mainstream media interviews giving substantial coverage of scientific issues related to test evaluation for COVID-19. Presented evidence to the House of Lords Select Committee, and the All Parliamentary Party Investigation on COVID-19 Diagnostic Test Accuracy Review editorial team Jacqueline Dinnes: no relevant interests; Editor, Cochrane Diagnostic Test Accuracy Review editorial team Yemisi Takwoingi: no relevant interests; Editor, Cochrane Infectious Diseases; Statistical Editor Diagnostic Test Accuracy Review editorial team no relevant interests; Contact Editor for Cochrane Diagnostic Test Accuracy Review editorial team and was not involved in the editorial process for this review no relevant interests; team member, Cochrane Diagnostic Test Accuracy Review editorial team René Spijker: none known Lotty Hoo : no relevant interests; editorial roles with the Cochrane Diagnostic Test Accuracy Review editorial team and Prognosis Methods Group implementation team Devy Emperador: no relevant interests; employed by FIND with funding from DFID and KFW. FIND is a global non-for profit product development partnership and World Health Organization Diagnostic Collaboration Centre. It is FIND's role to accelerate access to highquality diagnostic tools for low-resource settings and this is achieved by supporting both research and development, and access activities for a wide range of diseases, including COVID-19. FIND has several clinical research projects to evaluate multiple new diagnostic tests against published Target Product Profiles that have been defined through consensus processes. These studies are for diagnostic products developed by private sector companies who provide access to know-how Julie Domen: no relevant interests Stéphanie Janssens: no relevant interests; works as a general practitioner in training in 'De Wijkpraktijk' in Antwerp Dakshitha Wickramasinghe: none known Viktor Lannoy: none known Sebastiaan Horn: no relevant interests; works as a resident general practitioner: Praktijkhuis Baarle Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has Copyright © 2022 The Authors Outpatient Clinics, Hospital [statistics & numerical data]; Pandemics; Physical Examination; *Primary Health Care • Headache Are there concerns that the included patients and setting do not match the review question?High Were the index test results interpreted without knowledge of the results of the reference standard?Yes If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question?Low concern DOMAIN 3: Reference StandardIs the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question? Was there an appropriate interval between index test and reference standard?Unclear Did all patients receive the same reference standard? Were all patients included in the analysis? Yes Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? Could the conduct or interpretation of the index test have introduced bias? Are there concerns that the index test, its conduct, or interpretation differ from the review question?Low concern DOMAIN 3: Reference StandardIs the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Are there concerns that the target condition as defined by the reference standard does not match the question?Low concern Was there an appropriate interval between index test and reference standard?Yes Did all patients receive the same reference standard? Were all patients included in the analysis? Could the patient flow have introduced bias? Yonker 2020 (Continued) Purpose: diagnosis of SARS-CoV-2 infection (mild COVID-19 disease); to compare the symptoms of patients with positive and negative SARS-CoV-2 RT-PCR results and to determine the sensitivity, specificity, positive predictive value and negative predictive value for each of these symptoms in regard to SARS-CoV-2 RT-PCR Authors' judgement Risk of bias Applicability concerns DOMAIN Low concern DOMAIN 2: Index Test (All tests)Were the index test results interpreted without knowledge of the results of the reference standard? If a threshold was used, was it pre-specified? No Are there concerns that the index test, its conduct, or interpretation differ from the review question? Is the reference standards likely to correctly classify the target condition? Were the reference standard results interpreted without knowledge of the results of the index tests? Could the reference standard, its conduct, or its interpretation have introduced bias? Zurl 2021 (Continued) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 ( Presented below are all the data for all of the tests entered into the review. Test TST-187. Respiratory distress (retrospective data collection) Patients (setting, intended use of index test, presentation, prior testing)Primary care, hospital outpatient settings including emergency departmentsInpatients presenting with suspected COVID-19No prior testing Signs and symptoms often used for triage or referral The focus will be on the diagnosis of COVID-19 disease and COVID-19 pneumonia. For this review, the focus will not be on prognosis. This will be similar for all index tests, target conditions, and populations.YES: if a study explicitly stated that all participants within a certain time frame were included; that this was done consecutively; or that a random selection was done.NO: if it was clear that a different selection procedure was employed; for example, selection based on clinician's preference, or based on institutions.UNCLEAR: if the selection procedure was not clear or not reported. This will be similar for all index tests, target conditions, and populations.YES: if a study explicitly stated that all participants came from the same group of (suspected) patients.NO: if it was clear that a different selection procedure was employed for the participants depending on their COVID-19 (pneumonia) status or SARS-CoV-2 infection status.UNCLEAR: if the selection procedure was not clear or not reported. Studies may have excluded participants, or selected participants in such a way that they avoided including those who were difficult to diagnose or likely to be borderline. Although the inclusion and exclusion criteria will be different for the different index tests, inappropriate exclusions and inclusions will be similar for all index tests: for example, only elderly patients excluded, or children (as sampling may be more difficult). This needs to be addressed on a case-by-case basis.YES: if a high proportion of eligible patients was included without clear selection.NO: if a high proportion of eligible patients was excluded without providing a reason; if, in a retrospective study, participants without index test or reference standard results were excluded; if exclusion was based on severity assessment post-factum or comorbidities (cardiovascular disease, diabetes, immunosuppression). Cochrane Database of Systematic Reviews UNCLEAR: if the exclusion criteria were not reported. YES: if samples included were likely to be representative of the spectrum of disease.NO: if the study oversampled patients with particular characteristics likely to affect estimates of accuracy.UNCLEAR: if the exclusion criteria were not reported. HIGH: if one or more signalling questions were answered with NO, as any deviation from the selection process may lead to bias.LOW: if all signalling questions were answered with YES.UNCLEAR: all other instances.Is there concern that the included patients do not match the review question?HIGH: if accuracy of signs and symptoms were assessed in a case-control design, or in an already highly selected group of participants, or the study was able to only estimate sensitivity or specificity.LOW: any situation where signs and symptoms were the first assessment/test to be done on the included participants.UNCLEAR: if a description about the participants was lacking. This will be similar for all index tests, target conditions, and populations.YES: if blinding was explicitly stated or index test was recorded before the results from the reference standard were available.NO: if it was explicitly stated that the index test results were interpreted with knowledge of the results of the reference standard.UNCLEAR: if blinding was unclearly reported. This will be similar for all index tests, target conditions, and populations.YES: if the test was dichotomous by nature, or if the threshold was stated in the methods section, or if authors stated that the threshold as recommended by the manufacturer was used.NO: if a receiver operating characteristic curve was drawn or multiple threshold reported in the results section; and the final result was based on one of these thresholds; if fever was not defined beforehand.UNCLEAR: if threshold selection was not clearly reported. HIGH: if one or more signalling questions were answered with NO, as even in a laboratory situation knowledge of the reference standard may lead to bias.LOW: if all signalling questions were answered with YES.UNCLEAR: all other instances.Is there concern that the index test, its conduct, or interpretation differ from the review question?This will probably be answered 'LOW' in all cases except when assessments were made in a different setting, or using personnel not available in practice. Is the reference standard likely to correctly classify the target condition?We will define acceptable reference standards using a consensus process once the list of reference standards that have been used has been obtained from the eligible studies.For severe pneumonia, we will consider how well processes adhered to the WHO case definition in Appendix 1 . UNCLEAR: all other instances.Is there concern that the target condition as defined by the reference standard does not match the review question?HIGH: if the target condition was COVID-19 pneumonia, but only RT-PCR was used; if alternative diagnosis was highly likely and not excluded (will happen in paediatric cases, where exclusion of other respiratory pathogens is also necessary); if tests used to follow up viral load in known test-positives.LOW: if above situations were not present.UNCLEAR: if intention for testing was not reported in the study. Was there an appropriate interval between index test(s) and reference standard? We needed a more e icient approach to keep up with the rapidly increasing volume of COVID-19 literature. A classification model for this specific review was built with the model-building function within Eppi Reviewer, which uses the standard SGCClassifier in Scikit-learn on word trigrams. As outputs, new documents receive a percentage (from the predict_proba function) where scores close to 100 indicate a high probability of belonging to the class 'relevant document' and scores close to 0 indicate a low probability of belonging to the class 'relevant document'. We used three iterations of manual screening (title and abstract screening, followed by full-text review) to build and test classifiers. The final included studies were used as relevant documents, while the remainder of the COVID-19 studies were used as irrelevant documents. The classifier was trained on the first round of selected articles, and tested and retrained on the second round of selected articles. Testing on the second round of selected articles revealed poor positive predictive value but 100% sensitivity at a cut-o of 10. The poor positive predictive value is mainly due to the broad scope of our topic (any signs or symptoms associated with COVID-19)), poor reporting in abstracts, and a small set of included documents. JD, JDi, YT, CD, ML, RS, LH, AVdB, and DE, contributed clinical, methodological and/or technical expertise to dra ing the protocol. JD coordinated contributions from all co-authors and dra ed the protocol. ML dra ed the QUADAS-2 criteria. AVdB oversaw the overall progress of this review, participated in the selection process, data extraction, quality appraisal and dra ing of the manuscript. TS co-ordinated the review process, analysed the data, dra ed the manuscript and participated in the selection, data extraction and quality appraisal. JDo, DW, AT, VL, SJ and SH participated in the data extraction, quality appraisal, interpretation of the findings and commented on the manuscript.